Life Sciences Firm Working on Diabetes Cure
August 31, 2010
An Indiana company believes it is developing a potential cure for Type I diabetes. Ikotech, currently located at the Purdue Research Park of Southeast Indiana, utilizes technology used in the diagnostics of other diseases to turn pancreatic donations into viable tissues for patients. President David Kennedy talks to Inside INdiana Business Host Gerry Dick about the company.
Ikotech is a spinoff of Greenville-based Techshot Inc. and relocated from Ohio to Indiana to partner with Purdue University and its life sciences researchers.
January 30, 2015
Enterovirus D68 (EV-D68) is a member of Picornaviridae and is a causative agent of recent outbreaks of respiratory illness in children in the United States. We report here the crystal structures of EV-D68 and its complex with pleconaril, a capsid-binding compound that had been developed as an anti-rhinovirus drug. The hydrophobic drug-binding pocket in viral protein 1 contained density that is consistent with a fatty acid of about 10 carbon atoms. This density could be displaced by pleconaril. We also showed that pleconaril inhibits EV-D68 at a half-maximal effective concentration of 430 nanomolar and might, therefore, be a possible drug candidate to alleviate EV-D68 outbreaks.Read Full Story
January 12, 2015
Five Purdue University researchers received nearly $150,000 from the Trask Innovation Fund to further develop their technologies. The innovations originate from multiple disciplines and range from water purification to a drug-delivery technology.Read Full Story
December 18, 2014
Three Purdue University professors have been named fellows of the National Academy of Inventors.Read Full Story